• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail

Patent and Exclusivity Search Results from query on Appl No 202020 Product 002 in the OB_Rx list.

Patent Data

Appl No Prod No Patent No Patent
Drug Substance
Drug Product
Patent Use
N202020 002 6488960 Mar 14, 2020 Y U - 1267
N202020 002 6677326 Mar 14, 2020 Y U - 1268
N202020 002 8309124 Apr 23, 2024
N202020 002 8394407 Apr 23, 2024 Y U - 1362
N202020 002 9040085 Apr 23, 2024 U - 1362

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N202020 002 M - 128 Jul 26, 2015

Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2015
Patent and Generic Drug Product Data Last Updated November 27, 2015